Ocular Therapeutix Stock (NASDAQ: OCUL) stock price, news, charts, stock research, profile.
Open | $8.42 |
Close | $8.43 |
Volume / Avg. | 799.21K / 2.44M |
Day Range | 8.26 - 8.57 |
52 Wk Range | 2.00 - 11.31 |
Market Cap | $1.29B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 69 |
Short Interest | 13.21% |
Days to Cover | 11.98 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ocular Therapeutix (NASDAQ:OCUL) through any online brokerage.
Other companies in Ocular Therapeutix’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Verona Pharma (NASDAQ:VRNA), Tarsus Pharmaceuticals (NASDAQ:TARS) and Rapport Therapeutics (NASDAQ:RAPP).
There is no analysis for Ocular Therapeutix.
Ocular Therapeutix has a consensus price target of $15.50.
The stock price for Ocular Therapeutix (NASDAQ: OCUL) is $8.35 last updated July 26, 2024 at 6:15 PM EDT.
There are no upcoming dividends for Ocular Therapeutix.
Ocular Therapeutix’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Ocular Therapeutix.
Ocular Therapeutix is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.